BIO-key International (BKYI) Stock Analysis & Winston Score
BIO-key International makes software and hardware that uses fingerprints to verify who someone is before they can log into a computer system or access sensitive data. Its main products include fingerprint scanners and identity management software sold to businesses, hospitals, schools, and government agencies. The company operates in the biometric identity and cybersecurity industry, competing against much larger players like Microsoft and Okta. BIO-key earns money by selling its fingerprint reader devices and charging software licenses or subscription fees for its identity platform. It operates primarily in the United States but has pursued some international customers, particularly in Africa and the Middle East. The company is very small, with a market cap near zero, and has struggled to reach profitability, as its deeply negative operating margin shows. The biggest risk it faces is burning through cash before it can scale its customer base enough to cover costs.
Winston Score: 39/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (10/30)
- Growth: Good (12/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $3.85
Market Cap: $4M
Sector: Technology
Industry: Information Technology Services
Exchange: NASDAQ
